Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, announced today that it will be hosting a conference call on Thursday, August 10th at 10:00 a.m. EST, to discuss its second quarter 2006 financial results and provide an update on its lead development programs.
